TABLE 6.

Comparison of Observed SVR Among Patients With Available SVR Data and Combined Observed or Imputed SVR Among All Patients Who Initiated Antiviral Treatment

	Observed SVR (n = 19,286) (%, 95% CI)	Observed or Imputed SVR (n = 20,703) (%, 95% CI)*
All patients	89.6 (89.2–90.1)	88.8 (88.4–89.3)
White	89.8 (89.2–90.4)	89.1 (88.5–89.7)
Black	89.8 (89.1–90.6)	89.0 (88.2–89.9)
Hispanic	86.0 (83.8–88.1)	85.2 (83.0–87.3)
Asian/PI/AI/AN	90.7 (87.6–93.9)	90.3 (87.0–93.6)
Declined/missing	90.0 (88.7–91.2)	89.0 (87.7–90.3)

^*Imputed by multiple imputation using a logistic regression model that included duration of treatment together with 25 baseline patient characteristics shown in Table 1. The number of patients is slightly less than 21,095 due to missing data in the characteristics used to impute SVR.